Reaction
Drug Resistance Mutation reporting signals
As of the last recalculation, Drug Resistance Mutation appears in 174 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is OSIMERTINIB (PRR 239.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Osimertinib | 47 | 239.9 | 240.3 |
| Valganciclovir Hydrochloride Powder, | 16 | 172.7 | 172.9 |
| Ganciclovir Sodium | 13 | 158.7 | 158.9 |
| Ganciclovir | 12 | 150.6 | 150.7 |
| Valganciclovir | 19 | 135.2 | 135.3 |
| Valganciclovir Hydrochloride | 19 | 135.2 | 135.3 |
| Imatinib | 16 | 119.4 | 119.5 |
| Gefitinib | 8 | 111.1 | 111.2 |
| Crizotinib | 10 | 99.8 | 99.9 |
| Pemetrexed | 11 | 65.4 | 65.5 |
| Remdesivir | 7 | 65.4 | 65.5 |
| Erlotinib | 4 | 50.5 | 50.6 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 7 | 48.1 | 48.1 |
| Bosutinib | 3 | 40.6 | 40.6 |